Institutional members access full text with Ovid®

Share this article on:

Safety and Efficacy of Micafungin in Extremely Low Birthweight Infants.

Schüller, Simone S. MD; Bauer, Carina; Unterasinger, Lukas MSc; Berger, Angelika MD
Pediatric Infectious Disease Journal: Post Acceptance: September 28, 2017
doi: 10.1097/INF.0000000000001787
Brief Reports: PDF Only

Little is known about side effects of micafungin in extremely low birthweight (ELBW) infants. In a retrospective single center study 19 ELBW infants were analyzed for micafungin efficacy and safety. At a mean+/-SD daily dosage of 7.5 +/- 2.0mg/kg no clinically relevant side effects were observed. A significant increase of liver enzymes was reversible after treatment.

Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.